Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-423-0 | CAS number: 106-68-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Analogue based Read Across to 3-octanone (ethyl amyl ketone)
Methyl n-amyl ketone (MAK):
- Skin sensitisation (OECD 429): not sensitizing
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 29 June 2010 - 02 Mar 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- adopted 22 July 2010
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- No. 440/2008
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Batch No.of test material: TD-9024390
- Expiration date of the lot/batch: 01 November 2011
- Purity: 99.63%
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: room temperature in the dark
- Solubility and stability of the test substance in the solvent/vehicle: The test item was formulated within two hours of being applied to the test system. It is
assumed that the formulation was stable for this duration. No analysis was conducted to determine the homogeneity, concentration or stability of
the test item formulation. This is an exception with regard to GLP and has been reflected in the GLP compliance statement.
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: test item was used undiluted and freshly prepared as a solution in acetone/olive oil 4: 1
- Final dilution of a dissolved solid, stock liquid or gel: 50%
OTHER SPECIFICS: test material is a pale yellow liquid - Species:
- mouse
- Strain:
- CBA/Ca
- Remarks:
- CBN/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Harlan Laboratories U.K. Ltd., Oxon, UK.
- Females (if applicable) nulliparous and non-pregnant: yes
- Age at study initiation: eight to twelve weeks
- Weight at study initiation: 15 to 23 g
- Housing: suspended solid-floor polypropylene cages furnished with softwood woodflakes
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C):19 to 25°C
- Humidity (%): 30 to 70%,
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): twelve hours continuous light (06.00 to 18.00) and twelve hours darkness
- Other:The animals were provided with environmental enrichment items which were considered not to contain any contaminant of a level that might have affected the purpose or integrity of the study. - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 25%, 50% and 100%
- No. of animals per dose:
- 4
- Details on study design:
- PRE-SCREEN TESTS:
The mouse was treated by daily application of 25 μI of the undiluted test item to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The mouse was observed twice daily on Days 1, 2 and 3 and once daily on Days 4, 5 and 6.
Any signs of excessive local irritation noted during this period were recorded.
- Systemic toxicity: Any signs of toxicity noted during this period were recorded.
- Ear thickness easurements: The thickness of each ear was measured using an Oditest micrometer (Dyer, PA), pre-dose on Day 1, post dose on Days 2 and 3 and on Days 4 to 6. Any changes in the ear thickness were noted. Daily mean ear thickness values were calculated and the overall mean ear thickness changes were calculated for Days 2 to 5. A mean ear thickness increase of ~25% was considered to indicate excessive irritation and limited biological relevance to the endpoint of sensitisation.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA
- Criteria used to consider a positive response: The proliferation response of lymph node cells was expressed as the number of radioactive disintegrations per minute per lymph node (disintegrations per minute/node) and as the ratio of 3HTdR incorporation into lymph node cells of test nodes relative to that recorded for the control nodes (Stimulation Index). The test item will be regarded as a sensitiser if at least one concentration of the test item results in a threefold or greater increase in 3HTdR incorporation compared to control values. Any test item failing to produce a threefold or greater increase in 3HTdR incorporation will be classified as a "non-sensitiser".
TREATMENT PREPARATION AND ADMINISTRATION:
Groups of four mice were treated with the undiluted test item or the test item at concentrations of 50% or 25% v/v in acetone/olive oil 4: 1. The preliminary screening test suggested that the test item would not produce systemic toxicity or excessive local irritation at the highest suitable concentration. The mice were treated by daily application of 25 μI of the appropriate concentration of the test item to the dorsal surface of each ear for three consecutive days (Days 1, 2, 3). The test item formulation was administered using an automatic micropipette and spread over the dorsal surface of the ear using the tip of the pipette. A further group of four mice received the vehicle alone in the same manner.
Five days following the first topical application of the test item or vehicle (Day 6) all mice were injected via the tail vein with 250 μI of phosphate buffered saline (PBS) containing 3H-methyl thymidine (3HTdR: 80 μCi/ml, specific activity 2.0 Ci/mmol, ARC UK Ltd) giving a total of 20 μCi to each mouse. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Positive control results:
- a-Hexylcinnamaldehyde, tech., 85% induced a stimulation index of 7,25 and was thereforeconsidered to be a sensitiser under the conditions of the test.
- Key result
- Parameter:
- SI
- Value:
- 0.44
- Variability:
- not specified
- Test group / Remarks:
- Concentration 25%
- Key result
- Parameter:
- SI
- Value:
- 0.58
- Variability:
- not specified
- Test group / Remarks:
- Concentration 50%
- Key result
- Parameter:
- SI
- Value:
- 1.06
- Variability:
- not specified
- Test group / Remarks:
- Concentration 100%
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
The Stimulation Index is expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group
CLINICAL OBSERVATIONS:
There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test.
BODY WEIGHTS
Bodyweight changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group animals over the same period. - Interpretation of results:
- other: Not classified
- Remarks:
- Annex I of the CLP Regulation (1272/2008/EC)
- Conclusions:
- Based on the results in this study the compound does not need to be classified as a skin sensitizer in accordance with the criteria outlined in Annex I of the CLP Regulation (1272/2008/EC). This result is used for read-across to Ethyl Amyl Ketone.
- Executive summary:
A study was performed according to OECD Guideline 429 and Method 842 (EC) No. 440/2008 to assess the skin sensitisation potential of Methyl n-Amyl Ketone in the CBA/Ca strain mouse following topical application to the dorsal surface of the ear. Following a preliminary screening test in which no clinical signs of toxicity were noted at a concentration of 100%, this concentration was selected as the highest dose investigated in the main test of the Local Lymph Node Assay. Three groups, each of four animals, were treated with 50μI (25μI per ear) of the undiluted test item or the test item as a solution in acetone/olive oil 4:1 at concentrations of 50% or 25% v/v. A further group of four animals was treated with acetone/olive oil 4:1 alone. The Stimulation Index expressed as the mean radioactive incorporation for each treatment group ( 25%, 50% and 100%) divided by the mean radioactive incorporation of the vehicle control group were 0.44, 0.58 and 1.06 respectively. Indicating a negative result for all 3 dose groups. Therefore, the test item was considered to be a non-sensitiser under the conditions of the test does not need to be classified as a skin sensitizer in accordance with the criteria outlined in Annex I of the CLP Regulation (1272/2008/EC). This result is used for read-across to Ethyl Amyl Ketone.
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- See attached justification
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Parameter:
- SI
- Value:
- 0.44
- Variability:
- not specified
- Test group / Remarks:
- Concentration 25%
- Key result
- Parameter:
- SI
- Value:
- 0.58
- Variability:
- not specified
- Test group / Remarks:
- Concentration 50%
- Key result
- Parameter:
- SI
- Value:
- 1.06
- Variability:
- not specified
- Test group / Remarks:
- Concentration 100%
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
The Stimulation Index is expressed as the mean radioactive incorporation for each treatment group divided by the mean radioactive incorporation of the vehicle control group
CLINICAL OBSERVATIONS:
There were no deaths. No signs of systemic toxicity were noted in the test or control animals during the test.
BODY WEIGHTS
Bodyweight changes of the test animals between Day 1 and Day 6 were comparable to those observed in the corresponding control group animals over the same period. - Interpretation of results:
- other: Not classified
- Remarks:
- Annex I of the CLP Regulation (1272/2008/EC)
- Conclusions:
- Based on the information on read-across of the skin sensitisation using the source substance Methyl n-Amyl Ketone, the target compound Ethyl Amyl Ketone does not need to be classified as a skin sensitizer in accordance with the criteria outlined in Annex I of the CLP Regulation (1272/2008/EC).
- Executive summary:
A study was performed according to OECD Guideline 429 and Method 842 (EC) No. 440/2008 to assess the skin sensitisation potential of Methyl n-Amyl Ketone in the CBA/Ca strain mouse following topical application to the dorsal surface of the ear. Following a preliminary screening test in which no clinical signs of toxicity were noted at a concentration of 100%, this concentration was selected as the highest dose investigated in the main test of the Local Lymph Node Assay. Three groups, each of four animals, were treated with 50μI (25μI per ear) of the undiluted test item or the test item as a solution in acetone/olive oil 4:1 at concentrations of 50% or 25% v/v. A further group of four animals was treated with acetone/olive oil 4:1 alone. The Stimulation Index expressed as the mean radioactive incorporation for each treatment group ( 25%, 50% and 100%) divided by the mean radioactive incorporation of the vehicle control group were 0.44, 0.58 and 1.06 respectively. Indicating a negative result for all 3 dose groups. Therefore, the test item was considered to be a non-sensitiser under the conditions of the testdoes not need to be classified as a skin sensitizer in accordance with the criteria outlined in Annex I of the CLP Regulation (1272/2008/EC). This information is used for Read Accros to Ethyl Amyl Ketone (3-Octanone).
- Endpoint:
- skin sensitisation: in vitro
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
One key study is available for the source substance Methyl n-amyl ketone, performed according to OECD TG 429. The study was used for an analogue based Read Across to 3-octanone (ethyl amyl ketone)
Methyl n-amyl ketone (MAK):
A study was performed according to OECD Guideline 429 and Method 842 (EC) No. 440/2008 to assess the skin sensitisation potential of Methyl n-Amyl Ketone in the CBA/Ca strain mouse following topical application to the dorsal surface of the ear. Following a preliminary screening test in which no clinical signs of toxicity were noted at a concentration of 100%, this concentration was selected as the highest dose investigated in the main test of the Local Lymph Node Assay. Three groups, each of four animals, were treated with 50μI (25μI per ear) of the undiluted test item or the test item as a solution in acetone/olive oil 4:1 at concentrations of 50% or 25% v/v. A further group of four animals was treated with acetone/olive oil 4:1 alone. The Stimulation Index expressed as the mean radioactive incorporation for each treatment group ( 25%, 50% and 100%) divided by the mean radioactive incorporation of the vehicle control group were 0.44, 0.58 and 1.06 respectively. Indicating a negative result for all 3 dose groups. Therefore, the test item was considered to be a non-sensitiser under the conditions of the test does not need to be classified as a skin sensitizer in accordance with the criteria outlined in Annex I of the CLP Regulation (1272/2008/EC). This result is used for read-across to Ethyl Amyl Ketone.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the results in this study, methyl n-amyl ketone does not need to be classified as skin sensitising in accordance with the criteria outlined in Annex I of the CLP Regulation (1272/2008/EC).
From the available information and analogue based Read Across to 3-octanone (ethyl amyl keton), it is concluded that 3-octanone does not need to be classified as sensitizer in accordance with the criteria outlined in Annex I of the CLP Regulation (1272/2008/EC).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.